Post
The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
Novo Nordisk said an experimental obesity drug it is jointly developing with China’s United Laboratories International Holdings helped patients lose weight in a midstage clinical trial in China. on.wsj.com/40rgK7X
https://on.wsj.com/40rgK7X
2026-02-24T09:13:38.156Z